Beacon Financial Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$544K Sell
5,262
-114
-2% -$10.2K 0.05% 230
2026
Q1
$386K Sell
5,376
-190
-3% -$14.6K 0.04% 264
2025
Q4
$442K Buy
5,566
+18
+0.3% +$1.42K 0.04% 240
2025
Q3
$418K Sell
5,548
-540
-9% -$37K 0.04% 246
2025
Q2
$420K Sell
6,088
-190
-3% -$12.5K 0.04% 243
2025
Q1
$425K Sell
6,278
-6,026
-49% -$361K 0.05% 234
2024
Q4
$552K Sell
12,304
-2,769
-18% -$155K 0.06% 214
2024
Q3
$948K Sell
15,073
-1,469
-9% -$85.7K 0.1% 159
2024
Q2
$977K Sell
16,542
-962
-5% -$60.2K 0.11% 155
2024
Q1
$1.4M Sell
17,504
-728
-4% -$55.6K 0.16% 136
2023
Q4
$1.44M Buy
18,232
+986
+6% +$70.2K 0.18% 131
2023
Q3
$1.12M Buy
17,246
+5,684
+49% +$403K 0.16% 127
2023
Q2
$795K Sell
11,562
-852
-7% -$60.6K 0.11% 148
2023
Q1
$944K Buy
12,414
+7,450
+150% +$625K 0.13% 139
2022
Q4
$459K Buy
4,964
+3
+0.1% +$289 0.06% 188
2022
Q3
$481K Buy
4,961
+150
+3% +$14.8K 0.07% 180
2022
Q2
$450K Sell
4,811
-286
-6% -$27.9K 0.07% 189
2022
Q1
$523K Sell
5,097
-121,893
-96% -$12.8M 0.07% 191
2021
Q4
$13.2M Sell
126,990
-537
-0.4% -$49.6K 1.72% 10
2021
Q3
$11.1M Buy
127,527
+331
+0.3% +$27.7K 1.49% 13
2021
Q2
$10.4M Sell
127,196
-378
-0.3% -$31K 1.47% 12
2021
Q1
$9.58M Hold
127,574
1.5% 13
2020
Q4
$9.58M Sell
127,574
-5,562
-4% -$362K 1.5% 13
2020
Q3
$7.78M Sell
133,136
-5,639
-4% -$351K 1.39% 14
2020
Q2
$8.94M Sell
138,775
-35,283
-20% -$2.22M 1.72% 10
2020
Q1
$10.4M Sell
174,058
-2,072
-1% -$138K 2.28% 7
2019
Q4
$13.1M Sell
176,130
-1,774
-1% -$125K 1.64% 7
2019
Q3
$11M Buy
177,904
+5,708
+3% +$338K 1.88% 11
2019
Q2
$9.38M Sell
172,196
-2,521
-1% -$136K 1.6% 12
2019
Q1
$9.42K Buy
174,717
+50,024
+40% +$3.09M 1.54% 13
2018
Q4
$8.13M Sell
124,693
-9,741
-7% -$727K 1.52% 17
2018
Q3
$10.6M Sell
134,434
-3,512
-3% -$251K 1.79% 11
2018
Q2
$8.86M Buy
137,946
+45
+0% +$2.97K 1.5% 16
2018
Q1
$8.58M Buy
137,901
+10,956
+9% +$786K 1.46% 17
2017
Q4
$9.2M Buy
126,945
+62,765
+98% +$4.56M 1.6% 16
2017
Q3
$5.22M Buy
64,180
+1,405
+2% +$111K 0.94% 42
2017
Q2
$5.04M Buy
62,775
+4,642
+8% +$367K 0.96% 42
2017
Q1
$4.58M Buy
58,133
+45,026
+344% +$3.59M 0.88% 44
2016
Q4
$1.03M Sell
13,107
-2,539
-16% -$205K 0.21% 79
2016
Q3
$1.4M Buy
15,646
+2,311
+17% +$218K 0.29% 69
2016
Q2
$1.26M Buy
13,335
+423
+3% +$42.2K 0.27% 68
2016
Q1
$1.34M Buy
12,912
+770
+6% +$74.9K 0.29% 65
2015
Q4
$1.2M Sell
12,142
-362
-3% -$35.5K 0.28% 67
2015
Q3
$1.19M Buy
12,504
+1,375
+12% +$145K 0.29% 68
2015
Q2
$1.17M Buy
11,129
+1,826
+20% +$187K 0.25% 68
2015
Q1
$966K Buy
9,303
+2,491
+37% +$252K 0.21% 76
2014
Q4
$664K Sell
6,812
-2,122
-24% -$187K 0.14% 100
2014
Q3
$715K Sell
8,934
-17,598
-66% -$1.39M 0.16% 96
2014
Q2
$2.01M Buy
26,532
+1,875
+8% +$142K 0.44% 69
2014
Q1
$1.83M Sell
24,657
-304
-1% -$21.5K 0.38% 69
2013
Q4
$1.79M Sell
24,961
-6,216
-20% -$399K 0.34% 75
2013
Q3
$1.8M Buy
+31,177
New +$1.86M 0.39% 66

Other funds holding CVS

Beacon Financial Group's CVS Position: Q2 2026 in Review

Beacon Financial Group reduced its CVS Health (CVS) stake by 2.1% in Q2 2026, selling an estimated $10.2K and leaving 5,262 shares worth $544K. The position accounts for 0.05% of the portfolio, ranked #230.

Beacon Financial Group first reported a position in CVS in Q3 2013 and has held it in 52 quarters since. The position peaked at $13.2M in Q4 2021. 937 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Beacon Financial Group held 5,262 shares of CVS Health worth $544K as of Q2 2026.
  • Beacon Financial Group sold 114 CVS Health shares in Q2 2026, an estimated $10.2K.
  • CVS Health made up 0.05% of Beacon Financial Group's portfolio in Q2 2026, its #230 holding.
  • Beacon Financial Group first reported a position in CVS Health in Q3 2013 and has held it in 52 quarters since.
  • Beacon Financial Group's CVS Health position peaked at $13.2M in Q4 2021.
  • 937 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Beacon Financial Group's 13F filing for Q2 2026, filed 16 Jul 2026.